Michael J. Kirisits

1.4k total citations
15 papers, 878 citations indexed

About

Michael J. Kirisits is a scholar working on Parasitology, Organic Chemistry and Microbiology. According to data from OpenAlex, Michael J. Kirisits has authored 15 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Parasitology, 8 papers in Organic Chemistry and 4 papers in Microbiology. Recurrent topics in Michael J. Kirisits's work include Toxoplasma gondii Research Studies (11 papers), Antimicrobial agents and applications (5 papers) and Antimicrobial Peptides and Activities (4 papers). Michael J. Kirisits is often cited by papers focused on Toxoplasma gondii Research Studies (11 papers), Antimicrobial agents and applications (5 papers) and Antimicrobial Peptides and Activities (4 papers). Michael J. Kirisits collaborates with scholars based in United States and United Kingdom. Michael J. Kirisits's co-authors include Craig W. Roberts, Ernest Mui, Rima McLeod, David W. Rice, Stephen P. Muench, Wilbur K. Milhous, David Ferguson, Sean T. Prigge, Rima McLeod and Dennis E. Kyle and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Biochemistry.

In The Last Decade

Michael J. Kirisits

15 papers receiving 857 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Kirisits United States 13 466 297 276 167 146 15 878
Christine Pierrot France 17 292 0.6× 132 0.4× 245 0.9× 153 0.9× 311 2.1× 53 916
Técia Maria Ulisses de Carvalho Brazil 21 258 0.6× 769 2.6× 347 1.3× 132 0.8× 545 3.7× 37 1.2k
J. Robert Gillespie United States 19 138 0.3× 400 1.3× 533 1.9× 231 1.4× 231 1.6× 34 943
Lindsay B. Stewart United Kingdom 19 113 0.2× 95 0.3× 231 0.8× 87 0.5× 719 4.9× 42 995
Izabela Marques Dourado Bastos Brazil 19 99 0.2× 462 1.6× 338 1.2× 100 0.6× 346 2.4× 61 902
Tejinder Kaur India 11 44 0.1× 146 0.5× 209 0.8× 143 0.9× 177 1.2× 42 634
Juan Luís Concepción Venezuela 26 269 0.6× 1.2k 3.9× 854 3.1× 264 1.6× 840 5.8× 76 1.9k
María Cristina M. Motta Brazil 25 198 0.4× 1.2k 3.9× 686 2.5× 162 1.0× 715 4.9× 94 1.8k
Sylvain Biéler Switzerland 18 215 0.5× 370 1.2× 324 1.2× 26 0.2× 309 2.1× 36 937

Countries citing papers authored by Michael J. Kirisits

Since Specialization
Citations

This map shows the geographic impact of Michael J. Kirisits's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Kirisits with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Kirisits more than expected).

Fields of papers citing papers by Michael J. Kirisits

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Kirisits. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Kirisits. The network helps show where Michael J. Kirisits may publish in the future.

Co-authorship network of co-authors of Michael J. Kirisits

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Kirisits. A scholar is included among the top collaborators of Michael J. Kirisits based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Kirisits. Michael J. Kirisits is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Tipparaju, Suresh K., Stephen P. Muench, Ernest Mui, et al.. (2010). Identification and Development of Novel Inhibitors of Toxoplasma gondii Enoyl Reductase. Journal of Medicinal Chemistry. 53(17). 6287–6300. 45 indexed citations
2.
Hermes, Gretchen, James W. Ajioka, Krystyna A. Kelly, et al.. (2008). Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. Journal of Neuroinflammation. 5(1). 48–48. 170 indexed citations
3.
Mui, Ernest, Guy A. Schiehser, Wilbur K. Milhous, et al.. (2008). Novel Triazine JPC-2067-B Inhibits Toxoplasma gondii In Vitro and In Vivo. PLoS neglected tropical diseases. 2(3). e190–e190. 44 indexed citations
4.
Muench, Stephen P., Sean T. Prigge, Rima McLeod, et al.. (2007). Studies ofToxoplasma gondiiandPlasmodium falciparumenoyl acyl carrier protein reductase and implications for the development of antiparasitic agents. Acta Crystallographica Section D Biological Crystallography. 63(3). 328–338. 37 indexed citations
5.
Welti, Ruth, Sarah A. Wernimont, Giorgis Isaac, et al.. (2007). Lipidomic Analysis of Toxoplasma gondii Reveals Unusual Polar Lipids. Biochemistry. 46(48). 13882–13890. 63 indexed citations
6.
Muench, Stephen P., Sean T. Prigge, Li Zhu, et al.. (2006). Expression, purification and preliminary crystallographic analysis of theToxoplasma gondiienoyl reductase. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 62(6). 604–606. 11 indexed citations
7.
Mui, Ernest, David P. Jacobus, Wilbur K. Milhous, et al.. (2005). Triazine Inhibits Toxoplasma gondii Tachyzoites In Vitro and In Vivo. Antimicrobial Agents and Chemotherapy. 49(8). 3463–3467. 26 indexed citations
8.
Ferguson, David, Fiona L. Henriquez, Michael J. Kirisits, et al.. (2005). Maternal Inheritance and Stage-Specific Variation of the Apicoplast in Toxoplasma gondii during Development in the Intermediate and Definitive Host. Eukaryotic Cell. 4(4). 814–826. 69 indexed citations
9.
Samuel, Benjamin U., Brian R. Hearn, Douglas G. Mack, et al.. (2003). Delivery of antimicrobials into parasites. Proceedings of the National Academy of Sciences. 100(24). 14281–14286. 55 indexed citations
10.
Roberts, Craig W., Fiona Roberts, Russell E. Lyons, et al.. (2002). The Shikimate Pathway and Its Branches in Apicomplexan Parasites. The Journal of Infectious Diseases. 185(s1). S25–S36. 112 indexed citations
11.
Johnson, Jennifer E., Craig W. Roberts, Constance D. Pope, et al.. (2002). In Vitro Correlates of L d-Restricted Resistance to Toxoplasmic Encephalitis and Their Critical Dependence on Parasite Strain. The Journal of Immunology. 169(2). 966–973. 29 indexed citations
12.
McLeod, Rima, Stephen P. Muench, John B. Rafferty, et al.. (2001). Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of Apicomplexan Fab I. International Journal for Parasitology. 31(2). 109–113. 161 indexed citations
13.
Kirisits, Michael J., Ernest Mui, & Rima McLeod. (2000). Measurement of the efficacy of vaccines and antimicrobial therapy against infection with Toxoplasma gondii. International Journal for Parasitology. 30(2). 149–155. 25 indexed citations
14.
Kirisits, Michael J., et al.. (1994). Mapping of the TNFA locus in the rat. Immunogenetics. 39(1). 59–60. 12 indexed citations
15.
Kirisits, Michael J., et al.. (1994). Multiple TL-like loci in the grc-G/C region of the rat. Immunogenetics. 39(5). 301–315. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026